- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions ; volume:10 ; number:1 ; day:30 ; month:10 ; year:2018 ; pages:1-21 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (30.10.2018), 1-21, 12.2018
- Urheber
-
ten Kate, Mara
Ingala, Silvia
Schwarz, Adam J.
Fox, Nick C.
Chételat, Gaël
van Berckel, Bart N. M.
Ewers, Michael
Foley, Christopher
Gispert, Juan D.
Hill, Derek
Irizarry, Michael C.
Lammertsma, Adriaan A.
Molinuevo, José Luis
Ritchie, Craig
Scheltens, Philip
Schmidt, Mark E.
Visser, Pieter Jelle
Waldman, Adam
Wardlaw, Joanna
Haller, Sven
Barkhof, Frederik
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0438-z
- URN
-
urn:nbn:de:101:1-2018121901190508146720
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- ten Kate, Mara
- Ingala, Silvia
- Schwarz, Adam J.
- Fox, Nick C.
- Chételat, Gaël
- van Berckel, Bart N. M.
- Ewers, Michael
- Foley, Christopher
- Gispert, Juan D.
- Hill, Derek
- Irizarry, Michael C.
- Lammertsma, Adriaan A.
- Molinuevo, José Luis
- Ritchie, Craig
- Scheltens, Philip
- Schmidt, Mark E.
- Visser, Pieter Jelle
- Waldman, Adam
- Wardlaw, Joanna
- Haller, Sven
- Barkhof, Frederik
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
The “rights” of precision drug development for Alzheimer’s disease
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
The “rights” of precision drug development for Alzheimer’s disease
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
The “rights” of precision drug development for Alzheimer’s disease
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
The plasma peptides of Alzheimer’s disease
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Reproducibility of EEG functional connectivity in Alzheimer’s disease
Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease
Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study
Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease